327 related articles for article (PubMed ID: 33371874)
1. Deep learning detection of informative features in tau PET for Alzheimer's disease classification.
Jo T; Nho K; Risacher SL; Saykin AJ;
BMC Bioinformatics; 2020 Dec; 21(Suppl 21):496. PubMed ID: 33371874
[TBL] [Abstract][Full Text] [Related]
2. Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.
Cho H; Choi JY; Lee HS; Lee JH; Ryu YH; Lee MS; Jack CR; Lyoo CH
J Nucl Med; 2019 Nov; 60(11):1611-1621. PubMed ID: 30926651
[TBL] [Abstract][Full Text] [Related]
3. Quantitative
Zhao Q; Liu M; Ha L; Zhou Y;
Front Neurol; 2019; 10():486. PubMed ID: 31156534
[TBL] [Abstract][Full Text] [Related]
4. Machine learning application for classification of Alzheimer's disease stages using
Park SW; Yeo NY; Lee J; Lee SH; Byun J; Park DY; Yum S; Kim JK; Byeon G; Kim Y; Jang JW;
Biomed Eng Online; 2023 Apr; 22(1):40. PubMed ID: 37120537
[TBL] [Abstract][Full Text] [Related]
5. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
[TBL] [Abstract][Full Text] [Related]
6. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
[TBL] [Abstract][Full Text] [Related]
7. Deep learning application for the classification of Alzheimer's disease using
Park SW; Yeo NY; Kim Y; Byeon G; Jang JW
Sci Rep; 2023 May; 13(1):8096. PubMed ID: 37208383
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional associations between [
Teng E; Ward M; Manser PT; Sanabria-Bohorquez S; Ray RD; Wildsmith KR; Baker S; Kerchner GA; Weimer RM
Neurobiol Aging; 2019 Sep; 81():138-145. PubMed ID: 31280117
[TBL] [Abstract][Full Text] [Related]
9. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
[TBL] [Abstract][Full Text] [Related]
10. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
King-Robson J; Wilson H; Politis M;
J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
[TBL] [Abstract][Full Text] [Related]
11. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
12. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
13. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
15. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
[TBL] [Abstract][Full Text] [Related]
16. CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.
Spallazzi M; Barocco F; Michelini G; Immovilli P; Taga A; Morelli N; Ruffini L; Caffarra P
Acta Neurol Belg; 2019 Sep; 119(3):445-452. PubMed ID: 30847669
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Radiomic Features as New Biomarkers for Alzheimer's Disease: An Amyloid PET Study.
Ding Y; Zhao K; Che T; Du K; Sun H; Liu S; Zheng Y; Li S; Liu B; Liu Y;
Cereb Cortex; 2021 Jul; 31(8):3950-3961. PubMed ID: 33884402
[TBL] [Abstract][Full Text] [Related]
18. The Evaluation of Tau Deposition with [
Jantarato A; Vachatimanont S; Boonkawin N; Yaset S; Kunawudhi A; Promteangtrong C; Assanasen J; Mahanonda N; Chotipanich C
Mol Imaging; 2021; 2021():6640054. PubMed ID: 34381315
[TBL] [Abstract][Full Text] [Related]
19. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease.
Lu D; Popuri K; Ding GW; Balachandar R; Beg MF;
Med Image Anal; 2018 May; 46():26-34. PubMed ID: 29502031
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
